Dr. Gregory T. Austad, MD
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Cincinnati College of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 271
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: University of Cincinnati College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
UT license 5814204-1205 -
Internal Medicine Physician
UT license 5814204-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St. George Regional Hospital St George, UT
- Holy Cross Hospital-Davis Layton, UT
Medical groups
- Tanner Memorial Clinic (245 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 271
- Services billed
- 156,863
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 63,200 | 17 |
| Injection, golimumab, 1 mg, for intravenous use | 15,901 | 18 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,075 | 15 |
| Injection, infliximab, excludes biosimilar, 10 mg | 5,431 | 17 |
| Insertion of needle into vein for collection of blood sample | 477 | 164 |
| Blood test, comprehensive group of blood chemicals | 441 | 156 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 434 | 149 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 320 | 75 |
| Established patient office or other outpatient visit, 20-29 minutes | 260 | 143 |
| Established patient office or other outpatient visit, 30-39 minutes | 244 | 134 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Methotrexate (methotrexate sodium) Other prescribers in Layton, UT | 387 |
| Prednisone Other prescribers in Layton, UT | 234 |
| Hydroxychloroquine Sulfate Other prescribers in Layton, UT | 177 |
| Celecoxib Other prescribers in Layton, UT | 125 |
| Enbrel Sureclick (etanercept) Other prescribers in Layton, UT | 89 |
| Folic Acid Other prescribers in Layton, UT | 55 |
| Leflunomide Other prescribers in Layton, UT | 55 |
| Tramadol Hcl Other prescribers in Layton, UT | 55 |
| Leucovorin Calcium | 52 |
| Cyclobenzaprine Hcl Other prescribers in Layton, UT | 50 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 78 payments worth $1,057 in total to this clinician.
| Amgen Inc. | $427 |
|---|---|
| AbbVie Inc. | $220 |
| GlaxoSmithKline, LLC. | $99.23 |
| UCB, Inc. | $81.51 |
| Janssen Biotech, Inc. | $58.18 |
| Fresenius Kabi USA, LLC | $39.35 |
| Pfizer Inc. | $32.38 |
| Genentech USA, Inc. | $24.09 |
| Food and Beverage | $1,057 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.